Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Bioneer Corp (064550 KS)
Watchlist
17
Analysis
Health Care
•
South Korea
BIONEER Corp. provides molecular biology products & services. The Company's product includes oligo synthesis, nucleic acid amplication and purification kits, and instruments for detecting biowarfare agents.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
26 Nov 2021 15:16
New Covid Variant Raises Fear: Stocks to Own to Buck the Trend
Amidst the rising fear for the new Covid variant, investors can focus on molecular diagnostic stocks, as testing demand will be increasing again.
Tina Banerjee
Follow
606 Views
Share
bullish
•
SK Materials
•
25 Nov 2021 00:55
15 Adds & 15 Deletes in KOSDAQ 150 Rebalancing: Passive Impact & Trade Approaches
The KOSDAQ 150 December rebalancing features a total of 15 additions and 15 deletions. This post details the results as well as the passive impact...
Sanghyun Park
Follow
350 Views
Share
bullish
•
Coocon Corp
•
24 Nov 2021 12:11
KOSDAQ150 Index Rebalance: Pullback Done; Buy Adds & Sell Deletes
There are 15 changes for the KOSDAQ150 index in December. The impact on the deletions is larger than that on the inclusions. A long adds/short...
Brian Freitas
Follow
401 Views
Share
bullish
•
Bioneer Corp
•
10 Nov 2021 07:09
Bioneer Corp (064550 KS): Gaining Strength ‘With COVID’ and ‘Beyond COVID’; Poised to Rebound
This insight has mainly analyzed growth prospect of Bioneer's main business of molecular diagnostic beyond COVID-19. Its probiotic business has...
Tina Banerjee
Follow
221 Views
Share
bullish
•
M2N Co.,Ltd
•
02 Nov 2021 05:43
KOSDAQ150 Index Rebalance Preview: 15 Potential Changes and Large Turnover
At the end of the review period, we see 15 potential changes for the KOSDAQ150 index. Most of the changes are high probability. The adds could...
Brian Freitas
Follow
640 Views
Share
Previous
1
2
3
4
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.51.2
x